Eligible patients may use GLOW Blend injections at home after provider instruction
Published preclinical work often looks at cell migration, blood-vessel signalling, fibroblast activity, epithelial barrier models, and how local tissue environments respond under controlled conditions
Verify patient eligibility
Unaddressed inflammation: GHK-Cu is anti-inflammatory, but it works upstream, not against active inflammatory conditions
We focus on helping you achieve optimal cognitive health through treatments like Dihexa, a potent cognitive enhancer
In published preclinical work, KPV has been studied for inhibiting NF-B activation in intestinal epithelial cells, with one widely cited study showing PepT1-mediated transport into colonic cells as part of its anti-inflammatory mechanism in mouse colitis models (Dalmasso et al., Gastroenterology , 2008)